Renaissance Technologies
APYX icon

Renaissance Technologies’s Apyx Medical APYX Stock Holding History

Renaissance Technologies’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.12M Buy
302,395
+82,000
+37% +$306K ﹤0.01% 2220
2025
Q4 		$771K Sell
220,395
-1,302
-0.6% -$4.54K ﹤0.01% 2391
2025
Q3 		$474K Buy
221,697
+40,302
+22% +$85.3K ﹤0.01% 2814
2025
Q2 		$408K Sell
181,395
-20,600
-10% -$29K ﹤0.01% 2934
2025
Q1 		$277K Sell
201,995
-4,200
-2% -$5.79K ﹤0.01% 2953
2024
Q4 		$326K Buy
206,195
+2,900
+1% +$4.06K ﹤0.01% 3006
2024
Q3 		$252K Sell
203,295
-13,298
-6% -$16.8K ﹤0.01% 3047
2024
Q2 		$290K Sell
216,593
-35,424
-14% -$52.3K ﹤0.01% 2918
2024
Q1 		$343K Sell
252,017
-118,486
-32% -$252K ﹤0.01% 3030
2023
Q4 		$971K Sell
370,503
-33,904
-8% -$82.1K ﹤0.01% 2427
2023
Q3 		$1.29M Buy
404,407
+118,912
+42% +$554K ﹤0.01% 2127
2023
Q2 		$1.44M Sell
285,495
-45,600
-14% -$231K ﹤0.01% 2212
2023
Q1 		$954K Sell
331,095
-37,100
-10% -$108K ﹤0.01% 2509
2022
Q4 		$862K Sell
368,195
-59,900
-14% -$183K ﹤0.01% 2619
2022
Q3 		$1.92M Sell
428,095
-113,888
-21% -$816K ﹤0.01% 2041
2022
Q2 		$3.18M Buy
541,983
+29,977
+6% +$154K ﹤0.01% 1872
2022
Q1 		$3.34M Buy
512,006
+28,211
+6% +$278K ﹤0.01% 1852
2021
Q4 		$6.2M Sell
483,795
-100
-0% -$1.4K 0.01% 1384
2021
Q3 		$6.7M Sell
483,895
-35,100
-7% -$369K 0.01% 1284
2021
Q2 		$5.35M Buy
518,995
+5,200
+1% +$51.5K 0.01% 1595
2021
Q1 		$4.96M Sell
513,795
-40,600
-7% -$406K 0.01% 1654
2020
Q4 		$3.99M Sell
554,395
-5,400
-1% -$35.8K ﹤0.01% 1729
2020
Q3 		$2.64M Sell
559,795
-22,400
-4% -$111K ﹤0.01% 1964
2020
Q2 		$3.23M Sell
582,195
-55,400
-9% -$230K ﹤0.01% 1893
2020
Q1 		$2.29M Buy
637,595
+14,700
+2% +$98.7K ﹤0.01% 1983
2019
Q4 		$5.27M Sell
622,895
-29,905
-5% -$216K ﹤0.01% 1818
2019
Q3 		$4.42M Sell
652,800
-13,800
-2% -$97.9K ﹤0.01% 1862
2019
Q2 		$4.48M Sell
666,600
-9,507
-1% -$51.7K ﹤0.01% 1876
2019
Q1 		$4.27M Buy
676,107
+56,182
+9% +$435K ﹤0.01% 1908
2018
Q4 		$4.02M Buy
619,925
+70,225
+13% +$425K ﹤0.01% 1859
2018
Q3 		$3.9M Buy
549,700
+216,700
+65% +$1.2M ﹤0.01% 1955
2018
Q2 		$1.45M Buy
333,000
+1,600
+0.5% +$5.9K ﹤0.01% 2436
2018
Q1 		$984K Sell
331,400
-4,800
-1% -$12.4K ﹤0.01% 2667
2017
Q4 		$874K Buy
336,200
+2,900
+0.9% +$9.05K ﹤0.01% 2716
2017
Q3 		$1.13M Buy
333,300
+9,600
+3% +$24.8K ﹤0.01% 2535
2017
Q2 		$800K Buy
323,700
+17,900
+6% +$44K ﹤0.01% 2639
2017
Q1 		$816K Sell
305,800
-25,000
-8% -$83K ﹤0.01% 2616
2016
Q4 		$1.19M Buy
330,800
+82,400
+33% +$367K ﹤0.01% 2475
2016
Q3 		$1.29M Buy
248,400
+98,800
+66% +$320K ﹤0.01% 2433
2016
Q2 		$245K Buy
149,600
+22,600
+18% +$39.2K ﹤0.01% 2994
2016
Q1 		$212K Buy
127,000
+34,700
+38% +$69.8K ﹤0.01% 3064
2015
Q4 		$194K Buy
92,300
+32,900
+55% +$63.6K ﹤0.01% 3003
2015
Q3 		$116K Buy
59,400
+22,000
+59% +$50.4K ﹤0.01% 2991
2015
Q2 		$104K Buy
37,400
+23,200
+163% +$63.8K ﹤0.01% 3086
2015
Q1 		$34K Buy
+14,200
New +$47.2K ﹤0.01% 3097
2014
Q1 		– Sell
-11,600
Closed -$25K – 2805
2013
Q4 		$25K Sell
11,600
-13,400
-54% -$32.7K ﹤0.01% 2808
2013
Q3 		$71K Sell
25,000
-8,300
-25% -$25.4K ﹤0.01% 2721
2013
Q2 		$98K Buy
+33,300
New +$112K ﹤0.01% 2628

Other funds holding APYX

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Renaissance Technologies's APYX Position: Q1 2026 in Review

Renaissance Technologies increased its Apyx Medical (APYX) stake by 37% in Q1 2026, buying an estimated $306K and bringing the position to 302,395 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2220.

Renaissance Technologies first reported a position in APYX in Q2 2013 and has held it in 48 quarters since. The position peaked at $6.7M in Q3 2021. 67 funds tracked by Wall St. Rank hold APYX as of Q1 2026.

  • Renaissance Technologies held 302,395 shares of Apyx Medical worth $1.12M as of Q1 2026.
  • Renaissance Technologies bought 82,000 Apyx Medical shares in Q1 2026, an estimated $306K.
  • Apyx Medical made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #2220 holding.
  • Renaissance Technologies first reported a position in Apyx Medical in Q2 2013 and has held it in 48 quarters since.
  • Renaissance Technologies's Apyx Medical position peaked at $6.7M in Q3 2021.
  • 67 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.